Atomic AI Company
At Atomic AI, we are developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery. Our Platform Our proprietary platform leverages deep learning foundation models to discover and design RNAtargeted small molecules, RNAbased medicines, and RNA tools.
Investors
Connections from
Founded Date:
2020-01-01
Technology:
['BioTech & HealthTech', 'Education, Research & SocialTech']
Funding Status:
Early Stage Venture
Total Funding:
42000000.0
Employee Number:
11-50
Headquarters:
United States
Last Funding Date:
2023-01-25
Investors Number:
14.0
Last Funding Type:
Series A
Industry:
BioTech & Health Care